Nadeem Q. Mirza

Insider Reports History

Location
Doylestown, PA
Signature
/s/ John Hamill, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nadeem Q. Mirza:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. Chief Medical Officer Common Stock 6,730 $49,062 $7.29 01 May 2024 Direct
Aprea Therapeutics, Inc. Chief Medical Officer Stock Options (Right to Purchase) 26,920 01 May 2024 Direct

Insider Reports Filed by Nadeem Q. Mirza

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APRE Aprea Therapeutics, Inc. 01 May 2024 2 $0 4 Chief Medical Officer 02 May 2024, 16:16
APRE Aprea Therapeutics, Inc. 01 May 2024 0 $0 3 Chief Medical Officer 02 May 2024, 16:15